Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : COVID-19 Vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Preclinical
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Greffex completes COVID-19 vaccine, prepares for FDA animal testing
Details : Greffex said it did not use a living or killed virus for its vaccine and instead used an adenovirus-based vector vaccine, which are genetically engineered.
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
December 03, 2020
Lead Product(s) : COVID-19 Vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Preclinical
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
